Skip Navigation

An Open-Label, Multicenter, Phase II Study of CLR 131 in Patients with Relapsed or Refractory R/R Select B-Cell Malignancies CLOVER-1

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT02952508

Study #:
STUDY00141421

Start Date:
Nov 13, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02952508

View Complete Trial Details & Eligibility at ClinicalTrials.gov